Literature DB >> 6373946

Defective phagocytic and bactericidal function of polymorphonuclear leucocytes in patients with beta-thalassaemia major.

A T Skoutelis, E Lianou, T Papavassiliou, A Karamerou, K Politi, H P Bassaris.   

Abstract

The phagocytic and bactericidal activity of polymorphonuclear leucocytes (PMNL) obtained from 50 non-splenectomised patients with homozygous beta-thalassaemia was studied. Polymorphonuclear leucocytes suspended in the serum of patients from whom they were derived ingested fewer Escherichia coli, 72.2 +/- 21.8 (mean +/- s.d.) per 50 PMNLs compared with 144.5 +/- 36.8 bacteria phagocytosed by PMNLs from healthy volunteers and suspended in normal serum (P less than 0.01). Killing of ingested bacteria by the PMNLs from patients was also significantly reduced. These abnormalities are in part serum-associated and are due to the presence of heat-labile inhibitor(s) in the patients' serum. When PMNLs from patients were suspended in patients' heat-inactivated serum, phagocytosis increased to 99.2 +/- 29.2 (P less than 0.01). Similar improvement was noted in PMNL bactericidal activity. These abnormalities provide additional information that helps to explain the increased susceptibility to bacterial infections of patients with homozygous beta-thalassaemia.

Entities:  

Mesh:

Year:  1984        PMID: 6373946     DOI: 10.1016/s0163-4453(84)92414-9

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Neutrophil functions in patients with fractures of the upper end of the femur.

Authors:  N G Papadopoulos; P E Lianou; G P Lyritis; T J Papavassiliou
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

2.  Transient improvement of polymorphonuclear leukocyte function by splenectomy in beta-thalassemia.

Authors:  P E Lianou; H P Bassaris; A T Skoutelis; E G Votta; J T Papavassiliou; J P Phair
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

Authors:  Cyril Renassia; Sabine Louis; Sylvain Cuvellier; Nadia Boussetta; Jean-Christophe Deschemin; Didier Borderie; Karine Bailly; Joel Poupon; Pham My-Chan Dang; Jamel El-Benna; Sandra Manceau; François Lefrère; Sophie Vaulont; Carole Peyssonnaux
Journal:  Blood Adv       Date:  2020-08-25

4.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.